Key clinical point: For seriously ill patients with multidrug-resistant organisms (MDROs) in their gastrointestinal tract, fecal microbiota transplant (FMT) may result in fewer and less severe infections, as well as shorter hospital stays.

Major finding: At 6-months’ follow-up, 7 out of 17 evaluable patients were decolonized of MDROs.

Study details: An observational study involving 20 patients with MDROs.

Disclosures: The research was funded by the National Institute for Health Research and the Medical Research Council. The investigators reported no conflicts of interest.